Please assess the completion status of the following clinical trial:

Trial Title: Coronary Artery Revascularization in Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients with diabetes with severe coronary artery disease General Inclusion Criteria~1. Age at least 18 years old~2. Patients with either Type I or Type II diabetes with a documented HbA1c greater than site ULN (If not on diabetic medication must be confirmed by a blood glucose of \>126 mg/dL fasting, or \>200mg/dL non-fasting); OR on diabetic medication with a documented physician diagnosis of diabetes mellitus.~3. No child bearing potential (if female)~4. Patient competent to provide consent~   Exclusion Criteria:~   General Exclusion Criteria~5. Congenital heart disease~6. Coronary bypass surgery within the preceding one year~7. Need for concomitant cardiac surgery~8. AHA Class III decompensated heart failure or AHA Class IV heart failure~9. Undergoing PCI for hemodynamic instability related to acute STEMI~10. History of a hemorrhagic stroke~11. Severe bleeding diathesis~12. History of chronic pancreatitis~13. A severe co-morbid condition that is expected to limit life to less than two years~14. Embolic stroke in the past six months~15. Significant GI bleed within the last one month~16. Lack of adequate surgical conduit~17. Sensitivity to clopidogrel (Plavix)~18. Sensitivity to glycoprotein IIb/IIIa inhibitors~19. Chronic systemic steroid use~20. Participation in another trial with active intervention~21. Patient unable to be adequately followed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PCI (Type: ACTIVE_COMPARATOR): Percutaneous coronary intervention
- CABG (Type: ACTIVE_COMPARATOR): Coronary artery bypass graft (CABG)

Based on this trial design, predict the completion outcome and termination type (if applicable).